Access the full text.
Sign up today, get DeepDyve free for 14 days.
Hiroyuki Kobayashi, N. Hayashi, K. Hayashi, A. Yamataka, Geoffrey Lane, T. Miyano (2004)
Connective tissue growth factor and progressive fibrosis in biliary atresiaPediatric Surgery International, 21
Rohit Kohli, M. Cortés, N. Heaton, A. Dhawan (2017)
Liver transplantation in children: state of the art and future perspectivesArchives of Disease in Childhood, 103
C. Hsieh, Li-Tung Huang, Shin-Yee Lee, Chao-Cheng Huang, Ching-Lin Lee, J. Chuang, Chao-Long Chen (2008)
Evaluation of hepatocyte growth factor in patients with biliary atresia.Journal of pediatric surgery, 43 7
G. Shiota, J. Okano, H. Kawasaki, Tomokazu Kawamoto, Toshikazu Nakamura (1995)
Serum hepatocyte growth factor levels in liver diseases: Clinical implicationsHepatology, 21
R. Altman, J. Levy (1985)
Biliary atresia.Pediatric annals, 14 7
P. Vejchapipat, A. Theamboonlers, Rapeepan Chaokhonchai, V. Chongsrisawat, S. Chittmittrapap, Y. Poovorawan (2004)
Serum hepatocyte growth factor and clinical outcome in biliary atresia.Journal of pediatric surgery, 39 7
M. Narkewicz, A. Kasaragod, M. Lucia, Sean Pflummer, Ronald Sokol, Kurt Stenmark (2005)
Connective tissue growth factor expression is increased in biliary epithelial cells in biliary atresia.Journal of pediatric surgery, 40 11
Y. Tsau, C. Chen, M. Chang, R. Teng, M. Lu, P. Lee (1997)
Nephromegaly and elevated hepatocyte growth factor in children with biliary atresia.American journal of kidney diseases : the official journal of the National Kidney Foundation, 29 2
Toshikazu Nakamura (1990)
Structure and function of hepatocyte growth factor.Progress in growth factor research, 3 1
E. Hsu, M. Shaffer, Lucy Gao, C. Sonnenday, M. Volk, J. Bucuvalas, J. Lai (2017)
Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.Gastroenterology, 153 4
H. Tsubouchi, Yoshiyuki Niitani, S. Hirono, H. Nakayama, E. Gohda, N. Arakaki, O. Sakiyama, Kozo Takahashi, Masayoshi Kimoto, S. Kawakami, Minami Setoguchi, T. Tachikawa, Sadahito Shin, T. Arima, Y. Daikuhara (1991)
Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme‐linked immunosorbent assayHepatology, 13
R. Superina (2017)
Biliary atresia and liver transplantation: results and thoughts for primary liver transplantation in select patientsPediatric Surgery International, 33
O. Madadi-Sanjani, J. Kuebler, S. Dippel, A. Gigina, C. Falk, G. Vieten, C. Petersen, C. Klemann (2019)
Hepatocyte growth factor levels in livers and serum at Kasai-portoenterostomy are not predictive of clinical outcome in infants with biliary atresiaGrowth Factors, 37
K. Uto, Y. Inomata, S. Sakamoto, T. Hibi, H. Sasaki, M. Nio (2019)
A multicenter study of primary liver transplantation for biliary atresia in JapanPediatric Surgery International, 35
M. Kasai (1983)
Advances in treatment of biliary atresiaThe Japanese journal of surgery, 13
Makenzie Cook, E. Zavala (2019)
The finances of a liver transplant programCurrent Opinion in Organ Transplantation, 24
L. Pape, K. Olsson, C. Petersen, Reinhard Wasilewski, M. Melter (2009)
Prognostic value of computerized quantification of liver fibrosis in children with biliary atresiaLiver Transplantation, 15
F. Li, H. Zhao, K. Peng, Z. Gao, S. Huang, J. Tou, X. Shu, W. Gu (2016)
Expression of transforming growth factor-β1 and connective tissue growth factor in congenital biliary atresia and neonatal hepatitis liver tissue.Genetics and molecular research : GMR, 15 1
Principals of midwifery, including the diseases of women and children
Toshikazu Nakamura, K. Nawa, A. Ichihara (1984)
Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.Biochemical and biophysical research communications, 122 3
M. Kasahara, K. Umeshita, S. Sakamoto, A. Fukuda, H. Furukawa, S. Uemoto (2017)
Liver transplantation for biliary atresia: a systematic reviewPediatric Surgery International, 33
A. Asai, A. Miethke, J. Bezerra (2015)
Pathogenesis of biliary atresia: defining biology to understand clinical phenotypesNature Reviews Gastroenterology &Hepatology, 12
K. Uchida, M. Inoue, K. Otake, S. Yoshiyama, Y. Toiyama, J. Hiro, T. Araki, C. Miki, M. Kusunoki (2006)
The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia.Journal of pediatric surgery, 41 10
Kenneth Azarow, M.James Phillips, Anthony Sandler, Inga Hagerstrand, Riccardo Superina (1997)
Biliary atresia: should all patients undergo a portoenterostomy?Journal of pediatric surgery, 32 2
P. Vejchapipat, S. Poomsawat, Tawan Imvised, V. Chongsrisawat, S. Chittmittrapap, Y. Poovorawan (2008)
Overexpression of hepatic inducible nitric oxide synthase in biliary atresiaHepatology Research, 38
S. Yoshida, M. Nio, Y. Hayashi, R. Ohi, I. Kawamura, T. Goto (2003)
Serum insulinlike growth factor-I in biliary atresia.Journal of pediatric surgery, 38 2
Andrew Danielsen, N. Maihle (2002)
The EGF/ErbB Receptor Family and ApoptosisGrowth Factors, 20
BackgroundThe prognosis of biliary atresia (BA) remains difficult to predict. This study evaluated the roles of hepatocyte growth factor (HGF) and its receptor (C-met) towards clinical outcome and native liver survival.MethodsHepatic HGF and C-met expression were determined using immunohistochemistry from liver biopsies of 41 BA patients during Kasai operation, and 17 non-cholestatic patients. The HGF and C-met expression was visually scored as per its intensity and percentage of stained area. BA patients were classified as high- and low-HGF and C-met receptor status. Native liver survival was compared between the two groups at 3-year follow-up. Data are shown as median and range.Main resultsMedian age of BA patients was 2 (1–6) months. Hepatic HGF and C-met staining scores of BA patients were higher than those of non-cholestatic patients (P < 0.0001). There was a correlation between HGF and C-met staining scores (spearman r = 0.77, P < 0.0001). However, there was no association between their expression and early outcome at 6 months post-op. Mean follow-up time was 68.6 months. Survival analysis revealed that native liver survival at 1 year and 3 years were 88% and 77%, respectively. Additionally, 82.6% (19/23) of patients in the low-HGF group survived with native liver, compared with 66.7% (10/15) of those in high-HGF group (P = 0.436). For C-met expression, 78.6% (22/28) of low-score and 70% (7/10) of high score groups survived with native liver (P = 0.673).ConclusionsStrong expression of hepatic HGF and its receptor in BA patients was demonstrated. However, the expression was not associated with the early outcome and native liver survival. These results suggest that HGF involved in the liver pathology of BA but its expression cannot be used as a prognostic indicator. Small sample size of patients was a main limitation. Further studies are warranted to validate our findings.
Pediatric Surgery International – Springer Journals
Published: May 21, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.